Literature DB >> 20956179

Impact of exacerbations on COPD.

A Anzueto1.   

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) determine disease-associated morbidity, mortality, resource burden and healthcare costs. Acute exacerbation care requirements range from unscheduled primary care visits to emergency room, inpatient or intensive care, generating significant costs in COPD. Even after an exacerbation resolves, respiratory, physical, social and emotional impairment may persist for prolonged time. Frequent exacerbations, mainly in patients with severe COPD, accelerate disease progression and mortality. Thus, patients with frequent exacerbations have a more rapid decline in lung function, worse quality of life and decreased exercise performance. Management of COPD directed to reduce incidence and severity of exacerbations improves long-term health status and conserves health care resources and costs.

Entities:  

Mesh:

Year:  2010        PMID: 20956179     DOI: 10.1183/09059180.00002610

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  97 in total

1.  Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Joanne Sonstein; Jeffrey L Curtis; Uma S Sajjan
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

Review 2.  Optimizing Drug Therapies in Patients with COPD in the US Nursing Home Setting.

Authors:  Roy A Pleasants; Peter A Radlowski; H Edward Davidson
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

Review 3.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

4.  Impact of medical education program on COPD patients: a cohort prospective study.

Authors:  Cristian Oancea; Ovidiu Fira-Mladinescu; Bogdan Timar; Voicu Tudorache
Journal:  Wien Klin Wochenschr       Date:  2015-04-08       Impact factor: 1.704

Review 5.  Chronic obstructive pulmonary disease classification, phenotypes and risk assessment.

Authors:  Prasad Manian
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

6.  Associations of interleukin-1 gene cluster polymorphisms with C-reactive protein concentration and lung function decline in smoking-induced chronic obstructive pulmonary disease.

Authors:  Yu Wang; Karey Shumansky; Don D Sin; S F Paul Man; Loubna Akhabir; John E Connett; Nicholas R Anthonisen; Peter D Paré; Andrew J Sandford; Jian-Qing He
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Adherence to Pulmonary Rehabilitation in COPD: A QUALITATIVE EXPLORATION OF PATIENT PERSPECTIVES ON BARRIERS AND FACILITATORS.

Authors:  Gabriela R Oates; Soumya J Niranjan; Corilyn Ott; Isabel C Scarinci; Christopher Schumann; Trisha Parekh; Mark T Dransfield
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-09       Impact factor: 2.081

8.  The Trajectory of Dyspnea in Hospitalized Patients.

Authors:  Ernest DiNino; Mihaela S Stefan; Aruna Priya; Benjamin Martin; Penelope S Pekow; Peter K Lindenauer
Journal:  J Pain Symptom Manage       Date:  2015-11-24       Impact factor: 3.612

9.  Significance of the microbiome in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; John R Erb-Downward; Gary B Huffnagle
Journal:  Ann Am Thorac Soc       Date:  2013-12

Review 10.  Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.

Authors:  Farzaneh Sanei; Tom Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2016-05-18       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.